IVBXF — Innovent Biologics Inc/ADR
—
OTC ·
Unknown ·
Unknown ·
CIK 1774163 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
2026-03-26
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | — | — | — | — | 37,347,839,000 | 17,344,705,000 | 17,991,596,000 |
| Jun 2025 | — | — | — | — | 23,594,272,000 | 9,540,139,000 | 9,172,452,000 |
| Dec 2024 | — | — | — | — | 21,602,602,000 | 7,508,185,000 | 8,484,873,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-15,092,803,000
Inventory
$1,301,745,000
Receivables
—
ST Investments
$886,741,000
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$13,041,522,688
EBITDA
$1,310,151,936
Free Cash Flow
$3,228,137,984
Enterprise Value
$1,566,292,736
Total Cash
$18,231,445,504
Total Debt
$2,815,774,976
Shares Out
1,734,623,465
Trailing EPS
$0.07
Book Value
$1.65
ROE
5.0%
ROA
1.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 13,041,523,000 | 2,140,913,000 | 813,565,000 | 37,347,839,000 | 17,991,596,000 | — | 10,001,012,000 |
| Dec 2024 | 9,421,888,000 | 258,119,000 | -94,631,000 | 21,602,602,000 | 8,484,873,000 | — | 1,287,024,000 |
| Dec 2023 | 6,206,070,000 | -909,210,000 | -1,027,913,000 | 20,627,360,000 | 8,099,779,000 | — | 147,810,000 |
| Dec 2022 | 4,556,380,000 | -2,581,885,000 | -2,179,270,000 | 17,588,845,000 | 6,858,896,000 | — | -1,918,804,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| KLAC | KLA CORP | $332.50B | $254.54 | — |
| KXIAY | Kioxia Holdings Corporation/ADR | $288.33B | $52.80 | — |
| IBM | INTERNATIONAL BUSINESS MACHINES CORP | $255.87B | $272.24 | — |
| TMO | THERMO FISHER SCIENTIFIC INC. | $174.42B | $469.34 | — |
| SMERY | Siemens Energy AG/ADR | $150.30B | $176.65 | — |
News headlines (Yahoo Finance, 1h cache)
Global Value Stocks Trading Below Estimated Worth In June 2026
2026-06-15 09:38 · Yahoo
3 Asian Stocks Estimated To Be Trading At Discounts Of Up To 29.4%
2026-06-15 04:38 · Yahoo
2026 ADA | Innovent Presents Multiple Clinical and Preclinical Results of Next-Generation Obesity & Metabolic Pipeline
2026-06-08 08:30 · Yahoo
3 Asian Stocks Estimated To Be Priced Below Intrinsic Value In June 2026
2026-06-05 04:37 · Yahoo
3 Asian Stocks Estimated To Be Up To 43.2% Below Intrinsic Value
2026-06-04 22:34 · Yahoo
World's First CLDN18.2 ADC for Regulatory Review: Innovent Biologics Announces IBI343 (arcotatug tavatecan) Met Primary Endpoint in International Phase 3 Study in Advanced Refractory Gastric Cancer an
2026-06-04 08:35 · Yahoo
Dark Horse Consulting Group and Altruist Biologics Announce Memorandum of Understanding to Advance Biologics Manufacturing and Development in China
2026-06-03 11:00 · Yahoo
Is Pfizer Inc. (PFE) Expanding Its Cancer Pipeline Through a Landmark Innovent Partnership?
2026-06-02 14:11 · Yahoo
Why HUTCHMED (China) Limited (HCM) Is Gaining Attention After China Biotech Re-Rating
2026-06-02 13:58 · Yahoo
Pfizer Oncology Deal And Lung Cancer Data Reshape Valuation Debate
2026-06-01 15:11 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.